Coagulase Mannitol Agar Base

As low as $51.70
Availability: Out of stock
Availability: In stock
Only %1 left
SKU:
M272
For the primary isolation and differentiation of pathogenic Staphylococci from clinical specimens or For classifying pure cultures.


Intended Use

Recommended for primary isolation and identification of pathogenic Staphylococci from clinical specimens or for classifying pure cultures.

Composition**

Ingredients g / L
HI infusion$ 5.000
Tryptone 10.500
Soya peptone 3.500
Sodium chloride 3.500
Mannitol 10.000
Bromo cresol purple 0.020
Agar 14.500

Final pH (at 25°C): 7.4±0.2

**Formula adjusted, standardized to suit performance parameters

$ - Equivalent to Beef heart infusion (solids)

Directions

Suspend 47.02 grams in 1000 ml purified/distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving ∆ 118°C-121°C for 15 minutes. Cool to 45-50°C. Add 7-15% v/v sterile pretested, rabbit plasma to the basal medium. Mix well and pour into sterile Petri plates.

∆ corresponds to 12-15 lbs pressure.

Principle And Interpretation

The genus Staphylococcus comprises 28 accepted or proposed species, 14 of which may be encountered in human clinical specimens. Staphylococci are generally found on the skin and mucous membranes of humans and other animals. Some of the pathogenic staphylococci in both humans and animals produce an enzyme called coagulase and detection of this enzyme is used in the laboratory to identify these organisms (1).

These media are used for the isolation of Staphylococcus aureus from clinical specimens and for differentiation of S.aureus from other species on the basis of coagulase production and mannitol fermentation. Chapman for the first time introduced a medium for selective isolation and differentiation of Staphylococci (1). Tellurite-glycine media were designed by Zebovitz et al (2) and Marwin (3) for selectively isolating coagulase-positive Staphylococcal species. Present medium is based on Esber and Faulconer formulation (4). Mutant or old cultures of S.aureus may be weak coagulase producers. They should be freshly sub cultured and rechecked. Escherichia coli ferments mannitol and may be weakly coagulase positive. Coagulase production is dependent on the presence of a fermentable sugar like mannitol in this case. It is also dependent on the presence of a protein factor in the HI infusion and blood plasma (5). When mannitol is fermented, the pH of the medium surrounding the coagulase positive colonies drops. This drop in pH is indicated by the change in colour of the bromocresol purple indicator, which turns yellow and exhibits yellow zones around the colonies.

An opaque area of coagulated plasma forms around the colonies of coagulase positive organisms. Staphylococcus epidermidis is coagulase negative and mannitol non-fermenting species, which does not change the colour of the medium. Coagulase negative species may ferment mannitol and produce a yellow zone around the colonies but an opaque zone will not be formed.

Type of specimen

Clinical samples :skin and mucous membranes

Specimen Collection and Handling

For clinical samples follow appropriate techniques for handling specimens as per established guidelines (2,3). After use, contaminated materials must be sterilized by autoclaving before discarding.

Warning and Precautions

In Vitro diagnostic use only. For professional use only. Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling clinical specimens. Safety guidelines may be referred in individual safety data sheets.

Limitations

  1. Some mutant strains of S.aureus may show coagulase weak or negative reaction. The culture should be retested in case of doubt.
  2. Some strains of E.coli may show mannitol fermentation and weak coagulase positive reaction.
  3. Gram strain may help in distinguishing between species.

Performance and Evaluation

Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.

Quality Control

Appearance: Light yellow to light grey homogeneous free flowing powder

Gelling: Firm, comparable with 1.45% Agar gel

Colour and Clarity of prepared medium: Purple coloured, slightly opalescent gel forms in Petri plates

Reaction: Reaction of 4.7% w/v aqueous solution at 25°C. pH : 7.4±0.2

pH: 7.20-7.60

Cultural Response: Cultural characteristics observed with added 7-15% v/v sterile pretested, rabbit plasma at 35-37°C for 18-48 hours.

Organism Inoculum (CFU) Growth Recovery Mannitol fermentation Coagulase production
Staphylococcus epidermidis ATCC 12228 (00036*) 50-100 luxuriant >=70% negative reaction, purple colour negative reaction, no opaque zone formation
Staphylococcus aureus subsp. aureus ATCC 25923 (00034*) 50-100 luxuriant >=70% positive reaction, yellow colour positive reaction, colonies surrounded by opaque zone

Key : *Corresponding WDCM numbers.

Storage and Shelf Life

Store between 10-30°C in a tightly closed container and the prepared medium at 2-8°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition Seal the container tightly after use. Use before expiry date on the label. Product performance is best if used within stated expiry period.

Disposal

User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical sample must be decontaminated and disposed of in accordance with current laboratory techniques (2,3).

Reference

  1. Chapman, 1944, J. Bacteriol., 48:113.
  2. Isenberg, H.D. Clinical Microbiology Procedures Handbook. 2nd Edition.
  3. Jorgensen,J.H., Pfaller , M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1.
  4. Koneman E. W., Allen S. D., Janda W. M., Schreckenberger P. C., Winn W. C. Jr., 1992, Colour Atlas and Textbook of Diagnostic Microbiology, 4th Ed., J. B. Lippinccott Company.
  5. Marwin, 1958, Am. J. Clin. Pathol., 30:470.
  6. Esber and Faulconer, 1959, Am. J. Clin. Pathol., 32:192.
  7. Schaub and Merrit, 1960, Bull. Johns Hopkins Hosp., 106:25.
  8. Zebovitz, Evans and Nivens, 1955, J. Bacteriol., 70:686.
More Information
Product Name Coagulase Mannitol Agar Base
SKU M272
Product Type Regular
Physical Form Powder
Origin Animal
Packaging type HDPE
References 1. MacFaddin J., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. I, Williams andWilkins, Baltimore.
2.Finegold and Baron, 1986, Bailey and Scotts Diagnostic Microbiology, 7th ed., The C.V. Mosby Co., St. Louis.
3.Ewing, 1986, Edwards and Ewings Identification of Enterobacteriaceae, 4th ed., Elsevier Science Publishing Co., Inc., NewYork.
Customized Product Available No
Write Your Own Review
You're reviewing:Coagulase Mannitol Agar Base

Upsell Products